Day: January 27, 2025

WARREN, N.J., Jan. 27, 2025 (GLOBE NEWSWIRE) — Dr. Ryan Saadi, Chairman and founding CEO of Tevogen Bio (“Tevogen Bio Holdings Inc.” or “Company”) (Nasdaq: TVGN), a clinical-stage specialty immunotherapy biotech, congratulates Lynne Patton on being appointed Deputy Assistant to the President and Director of Minority Outreach. Ms. Patton will join the Office of Public Liaison and will be responsible for ensuring that President Trump continues to build upon his Election Day support from Blacks, Latinos and Women. Ms. Patton has been one of the Trump family’s longest serving and most trusted aides. Previously, Ms. Patton was the Regional Administrator for Federal Region II at the U.S. Department of Housing and Urban Development (HUD) and Senior Advisor to Secretary Ben Carson. At HUD, Ms. Patton worked tirelessly to bring accountability,...

EATONTOWN, N.J., Jan. 27, 2025 (GLOBE NEWSWIRE) — Climb Channel Solutions, an international specialty technology distributor and wholly owned subsidiary of Climb Global Solutions, Inc. (NASDAQ: CLMB) is proud to announce the promotion of two visionary leaders who have been instrumental in shaping the company’s growth and success. Kim Stevens has been elevated to Chief Marketing Officer (CMO), while Charles Bass assumes the newly created role of Chief Alliances Officer (CAO). These promotions mark a pivotal moment for Climb Channel Solutions as the company kicks off 2025 with unparalleled momentum, bolstered by more than 12 internal promotions announced during the recent Sales Kickoff, themed “Run With Us.” As the former Vice President of Worldwide Marketing, Kim Stevens has been the driving force behind groundbreaking marketing...

SOMERSET, N.J., Jan. 27, 2025 (GLOBE NEWSWIRE) — CareCloud, Inc. (the “Company”) (Nasdaq: CCLD, CCLDO, CCLDP), a leading provider of healthcare technology and generative AI solutions for medical practices and health systems nationwide, today held its special meeting (“Special Meeting”) of CareCloud’s common stock shareholders. At the Special Meeting, a record-breaking 10.8 million shareholders, representing 85% of the votes cast, approved an amendment to the Company’s Certificate of Incorporation to increase the Company’s authorized shares of common stock from 35 million to 85 million shares. “We thank our shareholders for their overwhelming support of our proposal,” said Stephen Snyder, Co-Chief Executive Officer of CareCloud. The detailed voting results are reflected in the Form 8-K to be filed today with the Securities and Exchange...

Kowloon, Hong Kong, Jan. 27, 2025 (GLOBE NEWSWIRE) — CTRL Group Limited (the “Company”) (NasdaqCM: MCTR), an integrated marketing and advertising services provider in Hong Kong specializing in mobile games promotion for the local market, today announced that R.F. Lafferty & Co., Inc., which acted as the representative of the underwriters of the Company’s initial public offering (the “IPO”), has exercised the full over-allotment option and purchased an additional 300,000 ordinary shares of the Company at the IPO price of $4.00 per share. As a result, the Company has raised an aggregate of $9.2 million in gross proceeds, before underwriting discounts and other related expenses, through the issuance of a total of 2,300,000 ordinary shares in the IPO. R.F. Lafferty & Co., Inc. acted as the representative of the underwriters,...

The Central Bank of Iceland Resolution Authority announced today that a resolution plan for Kvika has been approved and thereby a decision on the minimum requirement for own funds and eligible liabilities (MREL) for the bank, in accordance with the Act on Resolution of Credit Institutions and Investment Firms, no. 70/2020.  According to the Resolution Authority’s decision, Kvika’s MREL requirements are 22.0% of Total Risk Exposure Amount (MREL-TREA) and 6.0% of Total Exposure Measure (MREL-TEM). The decision is effective from the date of the announcement, and the bank is already considered to meet the MREL requirements.   For further information, please contact Kvika’s Investor Relations at ir@kvika.is or by phone at +354 540 3200. 

PetVivo Board Appoints Eldred as Executive Director to Lead Company Product Commercialization and Operations MINNEAPOLIS, MN, Jan. 27, 2025 (GLOBE NEWSWIRE) — PetVivo Holdings, Inc. (OTCQB: PETV, PETVW), a leading provider of biomedical therapeutics for equines and companion animals, has appointed Mike Eldred as the Company’s Commercialization and Operations Advisor. His appointment as an Executive Director by the Company’s Board of Directors draws upon Mr. Eldred’s 30 years of executive experience in animal health and the veterinary industry to ramp up its product development and sales efforts. For the past 20 years, Mr. Eldred served as President of North American Operations for Dechra Pharmaceutical, a global specialist in veterinary pharmaceuticals. He built Dechra’s North American subsidiary from the ‘ground up’ to become...